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Background: Different superparamagnetic iron oxide nanoparticles have been tested for their potential use in
cancer treatment, as they enter into cells with high effectiveness, do not induce cytotoxicity, and are retained for
relatively long periods of time inside the cells. We have analyzed the interaction, internalization and biocompatibility of
dimercaptosuccinic acid-coated superparamagnetic iron oxide nanoparticles with an average diameter of 15 nm and
negative surface charge in MCF-7 breast cancer cells.
Results: Cells were incubated with dimercaptosuccinic acid-coated superparamagnetic iron oxide nanoparticles for
different time intervals, ranging from 0.5 to 72 h. These nanoparticles showed efficient internalization and relatively
slow clearance. Time-dependent uptake studies demonstrated the maximum accumulation of dimercaptosuccinic
acid-coated superparamagnetic iron oxide nanoparticles after 24 h of incubation, and afterwards they were slowly
removed from cells. Superparamagnetic iron oxide nanoparticles were internalized by energy dependent endocytosis
and localized in endosomes. Transmission electron microscopy studies showed macropinocytosis uptake and
clathrin-mediated internalization depending on the nanoparticles aggregate size. MCF-7 cells accumulated these
nanoparticles without any significant effect on cell morphology, cytoskeleton organization, cell cycle distribution,
reactive oxygen species generation and cell viability, showing a similar behavior to untreated control cells.
Conclusions: All these findings indicate that dimercaptosuccinic acid-coated superparamagnetic iron oxide nanoparticles
have excellent properties in terms of efficiency and biocompatibility for application to target breast cancer cells.
Keywords: MCF-7 cells, Superparamagnetic iron oxide nanoparticles, Intracellular trafficking, Transmission electron
microscopy, Cellular uptake, Endocytosis, CytotoxicityBackground
Although huge efforts have led to worldwide advances in
cancer treatment, this multifactorial and heterogeneous
disease is still one of the major causes of death in devel-
oped countries [1,2]. In the recent years, several reports
have focused on the potential use of superparamagnetic
iron oxide nanoparticles (SPION) in cancer research.
These reports have raised great expectations because
SPION are a promising tool for biomedical applications,
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unless otherwise stated.and targeted therapy of cancer by hyperthermia and/or
releasing anti-cancer molecules, which can be combined
in theranostic approaches [3-5].
Factors such as size, shape and surface charge of nano-
particles (NPs) can determine their cellular internalization
and distribution and, thus, their effective performance
[6,7]. Furthermore, colloidal stability can be achieved,
which is essential to ensure reproducibility, as well as
to influence the amount of cellular loading and toxicity.
The possibility to modify the surface of these particles
with biologically active compounds enables transport of
therapeutic agents into specific target cells, increasing
specificity and avoiding the access of cytotoxic agents
to non-target tissues during the delivery process [8].
Different SPION have been tested for potential use in
cancer treatment by hyperthermia, as they enter into
cells with high effectiveness and without any cytotoxicity,This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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inside the cells [3]. The evaluation of the potential use of
these nanoparticles requires a precise knowledge of sur-
face modified SPION internalization mechanisms at the
ultrastructural level and resulting intracellular pathways,
as well as on the fate of SPION inside the cells. Factors
such as uptake rate and internalization dynamics are the
key to understand how an insufficient cellular accumula-
tion of nanoparticles can lead to usage limitations, for
example as imaging probes [9].
In the past few years, there has been a great interest
in applying nanotechnology for biomedical studies, in
particular for diagnostic and therapeutic purposes. How-
ever, the possible toxicity of nanoparticles to humans and
environment has become a question of absolute priority
in Nanomedicine [4-6,10].
In this regard, cell cultures are important first line
tools to screen therapeutic efficiency and safety of drugs
(nanoparticles included) and provide essential information
to understanding cell-nanoparticle interactions, before
moving to in vivo analysis [11]. Hence, any new magnetic
nanoparticle formulation with potential biomedical appli-
cations should be accompanied by a detailed study that
ensures both its effectiveness and safety. In this sense, sev-
eral specific parameters and experimental protocols for
assessing nanomaterial toxicity have been developed [10].
We have studied the interaction of dimercaptosuccinic
acid-coated superparamagnetic iron oxide nanoparticles
(DMSA-SPION) with breast cancer cells (MCF-7) in
culture. Monodisperse nanoparticles (around 15 nm in
diameter) with a high saturation magnetization value,
were surface modified by meso-2,3-dimercaptosuccinic
acid (DMSA) to ensure their dispersion and stability in
aqueous buffers and media [12]. Interaction, uptake of
the particles (0.05-0.4 mg ml−1), as well as their accumu-
lation and persistence inside cells after prolonged incu-
bation (up to 72 h), were assessed by combining optical
light and electron microscopy methods. This approach
allowed us to correlate the overall cell visualization with
the precise localization of SPION inside the cell, their
relationship to cell organelles and the analysis of particle
shapes and sizes. Furthermore, several cytotoxicity assays,
including cell morphology, analysis of cytoskeleton and
adhesion proteins, cell cycle distribution, measurement of
intracellular reactive oxygen species (ROS) levels and two
viability tests, have been carried out to evaluate biocom-
patibility of these nanoparticles.
Results and discussion
DMSA-SPION uptake and internalization in cultured cells
Size, shape and charge of iron oxide nanoparticles, as
well as cell type, are important parameters which affect
effective internalization of nanoparticles into cells in cul-
ture [13-16]. It has been well documented that positivelycharged magnetic nanoparticles (MNP) showed a higher
degree of internalization than neutral and negatively
charged MNP due to their effective attachment to nega-
tively charged cell-membrane surface [3,14,16]. Although
there are somewhat contradictory findings about cyto-
toxicity levels between positively or negatively charged
nanoparticles [3,17-19], the latter ones are favored due
to their overall lower toxicity levels.
Incorporation of DMSA-SPION into MCF-7 cells can
be followed by bright field microscopy after 24 h incuba-
tion (Figure 1A), where SPION are observed inside living
cells, distributed as brown cytoplasmic spots of different
sizes, always outside of the nucleus. Similar results have
been previously described for iron oxide nanoparticles
with different coatings and different sizes in HeLa (human
cervical adenocarcinoma) cell line [3,17].
In depth qualitative and quantitative studies on the
internalization of DMSA-SPION in MCF-7 cancer cells
were performed by both Prussian blue staining and
ferrozine-based assay. Figure 1B shows cells incubated with
DMSA-SPION for different times (0.5-72 h) by Prussian
blue staining. An increase of intracellular DMSA-SPION
accumulation was visualized as blue cytoplasmic granular
stain within cells directly correlating with incubation times.
However, the uptake of nanoparticles seems to reach a
saturation point at 24 h. It is important to note that 100%
cell labeling efficiency (Prussian blue positive staining)
was achieved after 12 h nanoparticles incubation.
These results were confirmed by colorimetric ferrozine-
based assay, a widely recognized test to quantify iron in
cultured cells [20]. Figure 1C shows intracellular iron con-
centrations after 24 and 48 h incubation at 0.4 mg ml−1
DMSA-SPION (20.67 pg cell−1 and 28 pg cell−1, respect-
ively). There is abundant literature with regard to
SPION-labeling efficiency, although results are difficult
to compare because the experimental protocols are differ-
ent (size and surface coating of the SPION, incubation
time, concentration, cell line type, etc.). Generally, pro-
longed incubation times, as well as elevated iron doses
enable to reach higher intracellular loading of SPION and
increase labeling efficiency [21,22]. However, overexposure
to high concentrations of SPION for extended times may
cause cytotoxicity [23]. Therefore, sufficient intracellular
uptake of nanoparticles for efficient diagnosis and/or
treatment must be balanced with their biocompatibility
[17]. In this sense, our results with ferrozine assay
indicate that DMSA-SPION accumulate effectively
(20.67 pg cell−1) within MCF-7 cells. Previously, we had
detected 37.1 pg cell−1 (into HeLa cells), after 24 h of
incubation at 0.5 mg ml−1 DMSA magnetic nanoparticles
with lower core diameter (9 nm). The small difference in
the amount of accumulated iron could be either due to
different of SPION diameters (15 vs 9 nm) or to the type
of cell line (HeLa vs MCF-7) [17]. Much lower amounts
Figure 1 Uptake and accumulation of DMSA-SPION into cells. (A) MCF-7 living cells visualized by bright field microscopy. (a) Control cells.
(b) Cells incubated with 0.4 mg ml−1 SPION for 24 h. Scale bar represents 10 μm. (B) Cells incubated with 0.4 mg ml−1 SPION for different time,
stained with Prussian blue reaction and visualized by bright field microscopy. (a) Control cells. (b-i) Cells incubated for 0.5, 1, 3, 6, 12, 24, 48 and
72 h, respectively. Scale bar represents 10 μm. (C) Intracellular iron content quantification by ferrozine assay (expressed as weight of iron per cell),
after 24 and 48 h of incubation. (D, E) Untreated and incubated MCF-7 (area, red filter), cell with DMSA-SPION. Representative images (D) and
quantitative box-plot of 100 cells per treatment (E). Details of x-axis: 1) Untreated cell only (background red filter), 2) Untreated, cell only (blue
filter), 3) Cell + SPION (total SPION), 4) Cell + SPION (total cell area, blue filter).
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bation with SPION (Feridex®) at 0.075 mg ml−1 in labeled
NPC (neural progenitor cells) [24].
Quantitative and statistical population analysis of total
iron oxide area per total cell area of 100 MCF-7 cellswas carried out by automated epifluorescence imaging
with multichannel acquisitions (bright field, blue and red
channels). From the overlapping and thresholding against
the iron content it was possible to identify and quantify
the ratio of inorganic iron content versus the total cell
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of untreated and exposed MCF-7 cells to 0.4 mg ml−1.
Samples from the same experiments were processed
for observation by electron transmission microscopy
(Figure 2). Even after very short incubation times (0.5 h),
it was possible to detect SPION clusters within cell cyto-
plasm (Figure 2a). DMSA-SPION were found surrounded
by a membrane and no free cytoplasmatic nanoparticles
were detected. Incubations of 1 and 3 h revealed a small
increment in the presence of vesicles containing DMSA-
SPION (Figure 2b, c). During longer incubation times
(6, 12 and 24 h), the number of vesicles with larger
DMSA-SPION aggregates increased and they were accu-
mulated close to the nuclei (Figure 2d-f and inset in f).
Together with an increment in the number of vesicles,
prolonged incubation time also resulted in important
morphological changes of DMSA-SPION containing vesi-
cles. While analysis of sectioned cells revealed a small in-
crement in their size, the most important change however
was related to their morphology, where a clear evolution
from translucent vesicles with nanoparticles towards a
much denser and multivesicular aspect has been detected
(Figure 2 a-f).
As MCF-7 cells are derived from a human breast
adenocarcinoma, we decided to study also DMSA-SPION
uptake and accumulation in a non-malignant breast cell
line MCF-10A. Cells were incubated with DMSA-SPION
under the same conditions as MCF-7 cells. Analysis byFigure 2 Electron microscopy analysis of uptake kinetics. Images from
for 0.5 h, (b) 1 h, (c) 3 h, (d) 6 h, (e) 12 h and (f) 24 h. The inset in (f) shows the
image, 200 nm for insets in a to e, and 2 μm for the inset in f, respectively.bright field microscopy showed that uptake and accumu-
lation of nanoparticles in MCF-10A cells was equivalent
to MCF-7 cancer cells (see Additional file 1). This was
confirmed by Prussian blue staining. Analysis by electron
microscopy clearly revealed that aggregates of particles
were accumulated inside MCF-10A cells near nucleus with
similar kinetics to that found in carcinoma cells (Additional
file 1). The overall response of these non-cancerous cells
was similar to carcinoma cells (see Additional file 1).
Results obtained for nanoparticles internalization in
malignant (MCF-7) and non-malignant (MCF-10A) cell
lines are not entirely surprising. It is important to recall
that all established cell lines, including non-malignant
cells, have alterations in their genome, which make them
different from healthy cells of an organism. Therefore,
MCF-10A cannot be considered as a fully “normal” hu-
man cell line [25,26]. In this sense, quantum dot (QD)
nanoparticles with different surface coatings can be
internalized within human mammary non-tumorigenic
epithelial cell line MCF-10A as well as in human mam-
mary adenocarcinoma epithelial cell line MCF-7 [27].
Zhang et al. [28] have described that both (MCF-7 and
MCF-10A) cells can internalize iron oxide nanoparticles
by vesicular transport after incubation for different times
(30 min, 4 and 24 h). This research was carried out
using commercial iron oxide nanoparticles (maghemite
γ-Fe2O3 with diameter around 30 nm) from Alfa Aesar®
(Karlsruhe, Germany) without any coating.thin sections of MCF7 cells incubated with DMSA-SPION. (a) Cells incubated
overall cell shape and morphology. Scale bars represent 1 μm for each
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with those reported in the literature previously, because
nanoparticles used in other studies have very different
characteristics. It is well known that parameters such as
nanoparticle size and particle surface coating are crucial
on nanoparticle-cell interactions [3,8,17,29].
Internalization mechanism and accumulation of
DMSA-SPION inside cells
To analyze internalization mechanism, cells were incu-
bated with particles at different temperatures. At 4°C, in-
ternalization of DMSA-SPION was inhibited and
nanoparticles were attached at the cell surface, while up-
take was developed successfully after 3 h at 37°C (Fig-
ure 3A). This result indicated that an active energy-
dependent transport was implicated in the SPION intern-
alization process [13,14,17,21].
To get insight into these nanoparticles subcellular
localization, MCF-7 cells were incubated with DMSA-
SPION for 24 h and then incubated with LysoTracker
Red to stain the lysosomal compartment and finally
visualized by bright field and fluorescence microscopy.
Figure 3B show SPION into MCF-7 living cells using
fluorescence microscopy. As can be seen in the same
figure lysosomes were labeled with LysoTracker Red.
Merged images displayed a substantial fraction of red
fluorescence from LysoTracker which colocalizes with in-
ternalized nanoparticles, strongly suggesting that DMSA-
SPION were accumulated in endosome/lysosome fraction.
To identify the precise mechanism of endocytosis
(phagocytosis, pinocytosis, macropinocytosis, clathrin-
mediated endocytosis, or caveolae-mediated endocytosis),Figure 3 Internalization mechanism and accumulation of DMSA-SPIO
(a, a’) Control cells. (b) Cells incubated at 4 °C for 3 h with DMSA-SPION. (b
10 μm. (B) Subcellular localization. (a, b) Visualization of control cells and c
respectively. (a’, b’) Lysosomes labeled with LysoTracker Red probe in the s
cells, respectively. Scale bar 20 μm.we performed transmission electron microscopy (TEM)
studies. The high contrast of the magnetic particles
allowed for their clear identification (Figure 4). Small
groups of particles were seen near cell membranes.
Actually, SPION incubated in culture media present a
relatively wide size distribution (ranging between 50 to
more than 400 nm, see Additional file 2). Although we
did not make an attempt to sort the SPION by size, we
found significant differences in the way the SPION were
incorporated in the cells according to the aggregate size.
Smaller aggregates were seen adjacent to distinct clathrin-
coated patches (Figure 4A). Closed clathrin vesicles con-
taining small DMSA-SPION aggregates (smaller than 200
nm) were seen in the cytoplasm, near membrane. Larger
DMSA-SPION aggregates were seen near cell periphery,
in most cases engulfed by cell membrane extensions, indi-
cating the existence of a macropinocytic DMSA-SPION
uptake process (Figure 4B a, b). Other studies have also
proposed a macropinocytic process for cationic iron oxide
nanoparticles internalization [30], as well as for other
nanoparticles [31].
Following short incubation times, particles were found
near the cell membrane, showing SPION-containing
vesicles closely resembling early endosomes (Figure 4C a).
At later incubation stages, there were denser SPION-
containing vesicles resembling multi-vesicular bodies con-
taining intraluminal vesicles (Figure 4C b). Subsequently,
the vesicles adopted a multi-lamellar lysosome aspect
containing large numbers of DMSA-SPION clusters
(Figure 4C c,d).
The same type of analysis has been carried out with
the non-malignant MCF10-A cells. The results clearlyN inside cells. (A) Temperature dependence of DMSA-SPION uptake.
’) Cells incubated for 3 h with same nanoparticles at 37 °C. Scale bars
ells incubated with nanoparticles for 24 h by bright field microscopy,
ame cells, respectively. (a”, b”) Overlay images of control and treated
Figure 4 Electron microscopy study of SPION interaction and uptake. (A) Electron microscopy images of thin sections of cells interacting
with DMSA-SPION by clathrin mediated uptake (<200 nm in diameter aggregates). Scale bar represents 200 nm. (B) Two images by electron
microscopy of thin sections of cells showing typical images of macropinocytosis for DMSA-SPION uptake (>200 nm in diameter aggregates).
Scale bars represent 200 nm. (C) Electron microscopy images of different types of endosomes containing SPION aggregates: (a) Early endosome.
(b) Multivesicular body containing intraluminal vesicles. (c) Late endosome characterized by a multilamellar morphology. (d) Late endosomes and
lysosomes with multivesicular structure and large electron-dense areas. Scale bar represents 200 nm.
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intracellular trafficking feature the same overall character-
istics in the case of the non-cancerous breast epithelial
cells (see Additional file 1).
Intracellular persistence of SPION
Other important questions related to the incorporation
of nanoparticles into cells are to establish how long they
remain inside cells and to disclose their eventual release
mechanism. To get an insight into these questions, after
24 h incubation, nanoparticles were removed and cultures
were further incubated up to 72 h at 37°C. Samples, taken
at 24, 48 and 72 h, were stained with Prussian blue and
observed by bright field microscopy. Figure 5A shows that
SPION remain within MCF-7 cells in vesicles up to 72 h.
To get more detailed information on the evolution of
the intracellular vesicles after prolonged incubation
times, a parallel analysis to that described above wascarried out using electron microscopy. Cells containing
DMSA-SPION evolved and divided in a similar way as
control cells without DMSA-SPION. Multi-vesicular
bodies and lysosomes containing nanoparticles did not
change much, even after extended incubation intervals
(Figure 5B a-d). SPION clusters were retained inside
the vesicles and these vesicles further evolved towards
late endosomal or lysosomal morphology, but neither
their number nor their localization in cell cytoplasm
underwent significant changes, thereby indicating that
DMSA-SPION were not massively released from cells.
These results suggest that, although cells keep dividing,
iron oxide nanoparticles persist inside them for a long
time. These qualitative results were confirmed by quantifi-
cation of intracellular iron content in ferrozine-based
assay (Figure 5C), which confirmed that the amount of
iron remains substantially unaltered inside the cells after
48 h post-incubation interval.
Figure 5 Persistence of internalized DMSA-SPION. (A) MCF-7 cells incubated with nanoparticles for 24 h, stained with Prussian blue reaction
after different post-incubation times and visualized by bright field microscopy. (a) Untreated control cells. (b-d) Cells incubated for 24 h and
stained 24, 48 and 72 h after incubation, respectively. Scale bar represents 10 μm. (B) Study of persistence by electron microscopy: (a) Cells were
incubated with DMSA-SPION for 24 h. The cells were further incubated in medium without particles for additional (b) 24 h, (c) 48 h and (d) 72 h.
Insets show larger magnification details of the endosomes. Scale bars represent 5 μm in overall areas and 500 nm in larger magnification insets,
respectively. (C) Intracellular iron content quantification by ferrozine assay (expressed as weight of iron per cell) in control (non-treated) cells (c),
and immediately (0) or 48 h after incubation with DMSA-SPION.
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Exposure to SPION has been associated with significant
toxic effects due to the generation of ROS, which result
in deleterious cellular consequences eventually leading
to cell death [32-35]. There are contradictory results
related to biocompatibility of DMSA-coated magnetic
nanoparticles. Several reports have described some cyto-
toxicity for DMSA magnetic iron oxide nanoparticles in
different cell lines [19,36]. On the contrary, little effects
on cell viability, oxidative stress, cell cycle or apoptosis
have been reported for these magnetic nanoparticles by
other authors [17,37].
Taking into account such a contradictory background,
we decided to analyze the biocompatibility of these
nanoparticles using several complementary approaches,
such as (i) studies of cytoskeletal components, (ii) cell
morphology observations by bright field microscopy
(neutral red and Hoechst-33258 staining), (iii) analysis of
the cell cycle, (iv) detection of ROS generation and, (v)
two alternative viability tests.
(i) Analysis of cytoskeletal components
Two components of cytoskeleton were analyzed: micro-
tubules (MTs) and actin filaments (F-actin). MTs are
highly dynamic fibers of the cytoskeleton, with critical
functions in eukaryotic cells including intracellular
transport, organization of cell structural dynamics and
cell division. We have evaluated the effects of nanoparti-
cle internalization on MTs during interphase and mitosis
by means of indirect immunofluorescence analysis to
α-tubulin (DNA counterstained with Hoechst-33258).
Figure 6A shows fluorescence images of MTs (green)
and DNA (blue) for interphase and metaphase MCF-7
control cells. After 24, 48 or 72 h of incubation with
nanoparticles, interphase microtubules maintain their
normal morphology and distribution. In the same sam-
ples, DMSA-SPION were visualized inside the cells by
bright field microscopy. Distributions of mitotic spindles
and chromosomes were also similar to metaphase control
cells up to 72 h after incubation.
We also investigated the effects of SPION on F-actin
and vinculin, a protein implicated in cell adhesion as a
focal adhesion complex component. F-actin builds the
thinnest filaments of cytoskeleton in the cytoplasm of
eukaryotic cells. They are involved in cell morphology,
transport of vesicles and organelles, positioning of cellu-
lar components, cytokinesis, cell motion, cell-cell and
cell-substrate interactions, and signal transduction. Focal
adhesions are specialized sites containing a complex net-
work of proteins, included vinculin, favoring interactions
between cell and extracellular matrix through the actin
cytoskeleton [38]. Figure 6B shows fluorescence images
of actin microfilaments (red), vinculin protein (green)
and DNA (blue) for MCF-7 control cells. Incorporationof DMSA-SPION, followed by localization of them in-
side the cells by bright field microscopy, did not affect
the organization of stress fibers or focal adhesions.
(ii) Cell morphology
MCF-7 cells were exposed to 24 h incubation with
DMSA-SPION and then they were stained with neutral
red or Hoechst-33258 to observe cytoplasmic and nuclear
morphology, respectively. Cells stained with neutral red
have a similar morphology to control cells after nanoparti-
cle incorporation in cytoplasm and, nuclei also presented
the same characteristics as control cells (Figure 7A).
(iii) Cell cycle
As shown in Figure 7B, cell cycle distribution was not
affected after incubation of cells with 0.4 mg ml−1
SPION for 24 h when compared to untreated control
populations. A broad overview of the effects of magnetic
and nonmagnetic nanoparticles on the cell life cycle has
been recently compiled by Mahmoudi et al. [39].
(iv) Detection of ROS generation
To analyze whether DMSA-SPION produce ROS, cells
were preincubated with SPION for 24, 48 and 72 h and
then treated with the fluorochrome probe DCFH-DA
[40]. As shown in Figure 7C, no significant fluorescent
signal was detected after 72 h incubation with SPION at
0.4 mg ml−1. Several in vitro studies have suggested that
a range of iron oxide nanoparticles with different
physico-chemical characteristics induce ROS formation
which can lead to cellular injury and death [32-35].
(v) Cell viability studies
MTT assay showed that cell viability was not signifi-
cantly affected by the presence of DMSA-SPION at 24 h
of treatment (>96% viability in relation to the control
sample), even at the highest concentration (0.4 mg ml−1)
(Figure 7D a). The results obtained using Trypan blue
assay (Figure 7D b), confirmed the biocompatibility of
DMSA-SPION, and cell survival was > 90% after 24 h
incubation. It is important to note that Trypan blue
exclusion test has been proposed as the gold standard
method to validate the cell viability after magnetic nano-
particle incubation [41]. These results were further con-
firmed using a multiparametric High Content Screening
Cytotoxicity Assay in agreement with a previously pub-
lished report [42], (data not shown).
In summary, the results presented here justify a deeper
research on the synthesis and biological characterization of
iron oxide nanoparticles. The complementary approaches
recommended for risk assessment of nanoparticles [43,44]
indicate that DMSA-SPION are safe and efficient nanopar-
ticles for possible biomedical applications. This is a crucial
fact, before further functionalization of these SPION for
Figure 6 Analysis of cytoskeleton. (A) Representative images of cells immunostained for α-tubulin (green) and DNA counterstained with
Hoechst-33258 (blue). (a) Interphase control cells. (a’) Metaphase control cell. (b-b’) Interphase cells incubated for 24 h with DMSA-SPION and observed
by fluorescence and bright-field microscopy, respectively; (c-c’) cells incubated for 48 h; (d-d’) cells incubated for 72 h. (e-e’) Mitotic spindle of cells
incubated for 24 h, (f-f’) 48 h and (g-g’) 72 h. (B) Merged images of F-actin labeled with rhodamine-phalloidin (red), vinculin immunostaining (green)
and DNA counterstained with Hoechst-33258 (blue). (a) Control untreated cells. (b-b’) Cells treated with DMSA-SPION for 24 h and observed by
fluorescence and bright-field microscopy, respectively. (c-c’) Cells incubated for 48 h. (d-d’) Cells incubated for 72 h. Scale bar 10 μm.
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that require high levels of intracellular accumulation for
effective treatment.
It is important to point out that the purpose of our
study was twofold: i) to analyze the effectiveness of
DMSA-SPION accumulation within tumor cells and ii)to confirm the absence of toxicity induced by nanoparti-
cles (non-functionalized), to ensure their biocompatibility,
even if they were accumulated by non-tumor cells. This is
especially important, taking into account the pressing
need to identify any potential cellular damage associated
with SPION [32]. In the broader context, following such
Figure 7 Cytotoxic studies. (A) Cell morphology by neutral red and Hoechst-33258 staining. (a-a’) Control cells. (b-b’) Cells incubated with
DMSA-SPION for 24 h. Scale bar represents 10 μm. (B) Cell cycle analysis of control (untreated) and cells incubated with SPION for 24 h. (C) Analysis of
ROS generation by DCFH-DA assay. Cells incubated with DMSA-SPION for different times and loaded with DCFH-DA were visualized under bright field
or fluorescence microscopy, respectively. (a, a’) Cells incubated with nanoparticles for 24 h. (b, b’) Cells incubated for 48 h. (c-c’) Cells incubated for
72 h. Scale bar represents 50 μm. (D) Cytotoxicity analysis in MCF-7 cells incubated DMSA-SPION for 24 h. (a) MTT cell viability assay after 24 h of
treatment with 0.05, 0.1 and 0.4 mg ml−1. (b) Trypan blue exclusion test immediately after incubation at 0.4 mg ml−1.
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will be further functionalized with biologically active
molecular moieties such as peptides and antibodies for
breast cancer targeting. From this prospective, our study
is relevant to the safe development of nanoparticles for
biomedical applications, as well as to understanding their
biological behavior in the “bare” or non-functionalized
state, since once delivered inside the cells, nanoparticles
can be processed by intracellular pathways (e.g. distinct
endocytic pathways) and “stripped” or separated from the
molecules they have been originally conjugated with.
Conclusions
Dimercaptosuccinic acid surface coating of SPION en-
hanced their cellular uptake efficiency without inducing
either cytotoxicity, alteration of the major cytoskeletal
components, vinculin protein dynamics, cell cycle or ROS
formation in MCF-7 breast cancer cell line. Incorporation
of DMSA-SPION inside the cells followed two endocytic
pathways depending on the size of the particle aggregates:
smaller aggregates were incorporated using a clathrin-dependent path, while larger aggregates were incorporated
by macropinocytosis. In all cases, SPION aggregates were
found surrounded by endocytotic membrane, which local-
ized in perinuclear areas after long incubation times,
but never inside the cell nucleus. Following cellular
uptake, SPION showed a slow release rate and continu-
ous persistence over extended intervals inside the cells.
These characteristics are relevant for the rational design
and subsequent utilization of SPION for biomedical appli-
cations, both for diagnosis by magnetic resonance imaging
(MRI) and for targeted therapy of cancer by hyperthermia
and releasing anti-cancer molecules with significantly
reduced side effects.
Methods
Magnetic nanoparticles
Superparamagnetic iron oxide nanoparticles of uniform
size (15 nm) were obtained by thermal decomposition of
an iron oleate complex in 1-octadecene [12]. These
particles, with a coating of DMSA that make them stable
in aqueous buffers, were kindly provided by Dr. Puerto
Calero et al. Journal of Nanobiotechnology  (2015) 13:16 Page 11 of 15Morales (ICMM-CSIC) as part of MULTFUN FP7 NMP
project (see details in Additional file 2).
DMSA-SPION were sterilized by 0.22 μm pore size fil-
tration (Millipore Corp., Bedford, USA). SPION stock
at 4 mg ml−1 was dispersed by sonication for 5 min in a
40 kHz sonicator bath (Branson 3510 ultrasonic cleaner,
Thomas Scientific, Swedesboro, USA). SPION were then
resuspended in complete cell culture media at a final con-
centration of 0.4 mg ml−1. The mixture was then soni-
cated for 1 min and incubated with cells at different times.
Cell cultures
Human breast cancer MCF-7 cells were grown as mono-
layer cultures in Dulbecco’s modified Eagle’s medium
(DMEM), supplemented with 10% (v/v) fetal bovine
serum (FBS), 50 units ml−1 penicillin and 50 μg ml−1
streptomycin. All products were purchased from Gibco
(Paisley, Scotland, UK) and sterilized by means of 0.22
μm filters. Cell cultures were grown in an incubator with
5% CO2 plus 95% air at 37°C. Depending on the purpose
of experiment, cells were seeded on 24-well plates (with
or without 10 mm square coverslips) or 25 cm2 flasks.
Sub-confluent cell cultures were used. All sterile plastics
were sourced from Corning (Corning Inc., New York,
USA).
Non-tumorigenic human breast epithelial cell line
MCF-10A was used for comparison in some experi-
ments (see Supporting Information). Cell lines used in
this study were obtained from American Type Culture
Collection (ATCC)®.
DMSA-SPION internalization
Live cell imaging
In order to analyze internalization of nanoparticles,
MCF-7 cells were grown on coverslips and incubated for
24 h with DMSA-SPION. After incubation, culture
medium was removed and samples were washed three
times with phosphate-buffered saline (PBS, pH 7.4).
Then, cells were observed immediately under bright
light microscopy without being processed, to avoid po-
tential fixation artifacts.
Prussian blue staining
Cells preincubated with nanoparticles for different periods
of time (0.5, 1, 3, 6, 12, 24, 48 or 72 h), were visualized by
Prussian blue staining for iron detection [17,45]. Briefly,
cells were fixed in methanol (at −20°C) for 5 min, stained
with an equal volume of 4% hydrochloric acid and 4%
potassium ferrocyanide trihydrate for 15 min, and coun-
terstained with 0.5% neutral red for 2 min. Preparations
were then washed with distilled water, air dried, and
mounted in DePeX (Serva, Heidelberg, Germany). All
other reagents were purchased from Panreac Química
(Montcada i Reixac, Spain).Quantification of iron in cultured cells
Colorimetric ferrozine-based method
This sensitive assay permits the quantification of iron in
cultured cells [46]. In time-dependent studies, MCF-7
cells seeded in 24-well plates were incubated with
DMSA-SPION at a fixed concentration of 0.5 mg ml−1
for 24 or 48 h. For intracellular persistence studies,
cells were incubated 24 h and intracellular iron content
was evaluated 48 h after removing DMSA-SPION from
culture media by three washes with PBS. After that, in
both cases, cells in three wells were trypsinized and cell
concentrations per well were determined by hemocy-
tometer with 0.4% Trypan blue solution. Cells grown in
other 24-well dishes were frozen at −20°C for 1 h and
then, 500 μl of 50 nM NaOH (Panreac Química) were
added to each well for 2 h in movement. Aliquots of
cell lysates were then transferred to 1.5 ml eppendorf
and mixed with 500 μl of 10 mM HCl, and 500 μl of
iron-releasing reagent (a freshly mixed solution of equal
volumes of 1.4 M HCl and 4.5% (w/v) KMnO4 (Merck,
Germany) in distilled H2O. These mixtures were incu-
bated for 2 h at 60°C within a fume hood, since
chlorine gas is produced during the reaction. After the
mixtures had cooled to room temperature, 150 μl of
iron-detection reagent (6.5 mM ferrozine (Sigma-Aldrich,
St Louis, USA), 6.5 mM neocuproine (Sigma-Aldrich),
2.5 M ammonium acetate (Panreac Química), and 1 M
ascorbic acid (Sigma-Aldrich) dissolved in water) were
added to each tube. After 30 min, 500 μl of the solution
obtained in each tube was transferred into a well of a
24-well plate, and absorbance was measured at 570 nm
in a SpectraFluor spectrophotometer (Tecan Group
Ltd., Männedorf, Switzerland). Iron content of the sam-
ple was calculated by comparing its absorbance to that
of a range of standard concentrations of equal volume,
that had been prepared in a way similar to that of the
sample (mixture of 100 μl of FeCl3 standards (0–300
μM) in 10 mM HCl, 100 μl 50 mM NaOH, 500 μl
releasing reagent, and 1500 μl detection reagent). The
determined intracellular iron concentration for each
well of a cell culture was normalized against number of
cells per well.High content screening
Quantification of iron oxide content was based on auto-
mated epifluorescence images taken from stained cell
monolayer cultured on slides. On average 100 cells were
selected from the two cell line provided. Images were
analyzed by single channel, filtered and threshold of each
channel was identified. Composite rebuilt in order to
identify localization of SPION against cellular staining.
Filtering was applied on the red and blue filter in order
to account for the SPION or the cell only.
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In order to analyze the degree of involvement of the endo-
cytic mechanisms in internalization of nanoparticles, cells
were preincubated with nanoparticles for 3 h at either 4°C
or 37°C, washed three times with PBS, and stained with
Prussian blue technique (as described above).
Subcellular localization of nanoparticles
To determine DMSA-SPION subcellular location inside
cells, endocytic compartments of MCF-7 cells were labelled
with 50 nM LysoTracker® Red DND-99 (Molecular Probes,
Eugene, Oregon, USA) fluoroprobe in culture medium, at
37°C for 30 min. Cells incubated with nanoparticles for 24
h were labelled with LysoTraker Red and then coverslips
were washed with PBS and cells were observed immediately
under bright field and fluorescence microscopy.
Analysis of the cytoskeleton and adhesion proteins
Immunofluorescence staining of α-tubulin
Cells grown on glass coverslips were incubated with nano-
particles for 24, 48 and 72 h and then, immunostained for
α-tubulin. Briefly, cells were fixed with cold methanol for
5 min, washed three times for 5 min with PBS, and then
permeabilized with 0.5% Triton X-100 (Sigma-Aldrich) in
PBS for 5 min. After Triton removal, cells were incubated
with primary monoclonal mouse anti-α-tubulin antibody
(Sigma-Aldrich) diluted 1:100 at 37°C in a wet chamber
for 1 h. Three washings with PBS were then carried out
before addiction of Triton X-100 for 5 min. Incubation of
the secondary antibody (Fab specific goat anti-mouse
FITC-IgG; Sigma-Aldrich) was identical to that of the first
one. Then, DNA was counterstained by Hoechst-33258
(0.05 mg ml−1 in distilled water) for 5 min. Finally, cells
were washed with PBS and mounted with ProLong Gold
(Molecular Probes) antifade reagent.
Vinculin immunofluorescence and F-actin staining
For vinculin immunostaining, cells grown on coverslips
were fixed with formaldehyde in PBS (1:10 v/v), for 20
min at 4°C, washed three times for 5 min with PBS and
permeabilized with 0.5% Triton X-100. After incubation
with a blocking solution (5% bovine serum albumin, 5%
FBS, 0.02% Triton X-100 in PBS) at room temperature
for 30 min, cells were incubated with 1:50 solution
mouse monoclonal anti-vinculin (Sigma-Aldrich) at 37°C
in a wet chamber for 1 h. Primary antibody binding was
detected using Fab specific goat anti-mouse FITC-IgG
diluted 1:50. F-actin was visualized in the same sam-
ples by incubation with rhodamine-labeled phalloidin
(Sigma-Aldrich) diluted 1:200 at 37°C in a wet chamber
for 25 min. Then, samples were washed three times with
PBS, counterstained with Hoechst-33258 for 5 min,
washed with PBS and mounted with Prolong Gold anti-
fade reagent.Cell morphology analysis
Neutral red staining
MCF-7 cells grown on coverslips in 24-well plates were
incubated with DMSA-SPION for 24 h, fixed in methanol
at −20°C for 5 min and then stained with 0.5% neutral red
for 2 min. After that, samples were washed with distilled
water, air dried, mounted in DePeX and visualized by light
microscopy.
Hoechst-33258 staining
Cells seeded on coverslips and treated with nanoparticles
for 24 h were fixed in methanol at −20°C for 5 min and
stained with Hoechst-33258 for 5 min. Samples were
washed with distilled water, air dried, and mounted in
DePeX for observation using fluorescence microscopy.
Cell cycle analysis
MCF-7 cells were plated in 25-cm2 flasks and incubated
with DMSA-SPION for 24 h. Analysis of cell cycle was
performed by flow cytometry using propidium iodide
(PI) labeling of DNA cell content. Cells were trypsinized
(also harvesting possible detached cells) and centrifuged
at 1200 rpm for 5 min. After centrifugation, pellet was
resuspended in 100 μl of culture medium without phe-
nol red. Then, it was added 50 μl of Coulter DNA Prep
Reagents Kit (Beckman-Coulter Inc, California, USA), 1
ml of PI solution with RNase and incubated for 30 min
at 37°C. Both reagents were purchased from Sigma-
Aldrich. Distribution of cells in different phases of cell
cycle was determined using a Coulter Epics XL-MCL
flow cytometer (Beckman-Coulter Inc.) with an argon
laser line (488 nm), complemented with appropriate
filters, and a minimum of 104 labeled cells per sample
were analyzed in each experimental condition. Percent
of cells in each phase of the cell cycle was compared
with that of control cells (without nanoparticles incuba-
tion). At least 10000 fluorescent events were counted
per sample.
Measurement of intracellular ROS
Intracellular ROS levels were determined using 2′,7′-
dichlorodihydrofluorescein diacetate (DCFH-DA) assay.
Cells were seeded on coverslips and, after exposure to
nanoparticles for 24, 48 and 72 h, were washed with PBS
and incubated with 10 μM DCFH-DA (Sigma-Aldrich)
for 30 min. Then, cells were washed with PBS again and
visualized immediately by fluorescence microscopy.
Bright field microscopy was also used to corroborate
accumulation of nanoparticles. For control induction of
oxidative stress, cells were treated with 800 μM H2O2
(Panreac Química) for 1 h 30 min in complete medium.
ROS production was observed in cells, 1 h 30 min
after that H2O2 was removed, with 10 μM DCFH-DA
for 30 min.
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MTT test
Cytotoxicity was assessed by MTT colorimetric assay 24
after incubation with DMSA-SPION. Immediately prior
to use, a stock solution of dimethylthiazolyl-diphenyl-
tetrazolium bromide (MTT; Sigma-Aldrich, 1 mg ml−1)
in PBS was prepared. Five hundred microliters of this
MTT solution (50 μg ml−1 MTT in culture medium)
was added to each culture dish without coverslip. Cells
were incubated for 3 h, then reduced formazan was
extracted with 500 μl dimethylsulfoxide and absorbance
measured at 570 nm in a SpectraFluor spectrophotom-
eter (Tecan Group Ltd, Männedorf, Switzerland). Cell
survival was expressed as the percentage of absorption
of treated cells in comparison with that of control cells.
Trypan blue exclusion test
Cell viability was quantified by Trypan blue dye exclusion
method. Briefly, after 24 h of incubation with DMSA-
SPION, trypsin was added to control and treated cells.
After cells were detached from the plate, they were
resuspended in culture media. Equal volumes of each cell
suspension and trypan blue solution (0.2% in PBS) were
mixed and used for cell counting by hemocytometer.
Blue-stained cells were counted as nonviable cells and
unstained cells as viable cells.
Bright field and fluorescence microscopy
Observation of samples processed for bright field and
fluorescence microscopy were made with an Olympus
BX61 epifluorescence microscope, equipped with an
Olympus DP50 digital camera (Olympus, Tokyo, Japan),
and processed using the Adobe Photoshop 7 software
(Adobe Systems, San Jose, CA, USA). The following filters
were used to visualize the fluorescence signal of probes:
UV excitation light (365–390 nm) for Hoechst-33258,
blue (460–490 nm) for FITC, and green (510–550 nm) for
TRITC.
Statistical analysis
Statistical analysis was performed by GraphPad Prism
Software (GraphPad Inc., CA, USA) using one-way
ANOVA and Tukey’s test. The threshold for significance
was P = 0.05 and P values < 0.05 (*), < 0.01 (**) and <
0.005 (***) were considered as significant.
Sample preparation for transmission electron microscopy
MCF-7 cells were incubated with SPION at different
times, as described above, washed with PBS and treated
with a mixture of 2% formaldehyde (Ultra Pure EM Grade,
Polysciences Inc., Philadelphia, USA) and 2.5% glutaralde-
hyde (EM Grade, TAAB Laboratories Equipment Ltd.,
Berks, UK) in PBS for 1 h at room temperature. The cell
monolayer on the coverslips was then washed with PBSand distilled water, post-fixed for 45 minutes with 1%
osmium tetroxide (TAAB Laboratories Equipment Ltd.)
in PBS, washed with distilled water, treated during 45
minutes with 1% aqueous uranyl acetate (Electron Micros-
copy Sciences, Hatfield, USA), washed again and dehy-
drated with growing quantities (50%, 75%, 95% and 100%)
of ethanol seccosolv (Merck KGaA, Darmstadt, Germany).
The samples were maintained in coverslips throughout
the process and finally embedded in epoxy resin 812
(TAAB Laboratories Equipment Ltd.) contained in gel-
atine capsules (Electron Microscopy Sciences). The epoxy
resin was polymerized for 2 days at 60°C. Resin was
detached from the coverslips by successive immersions in
liquid nitrogen and hot water. Ultrathin, 70-nm-thick
sections were obtained with an Ultracut UCT ultramicro-
tome (Leica Microsystems), transferred to 200 mesh
Nickel EM grids (Gilder, Lincolnshire, UK) and stained
with 3% aqueous uranyl acetate (10 minutes) and lead cit-
rate (2 minutes) (Electron Microscopy Science). Sections
were visualized on a JEOL JEM 1200 EXII electron micro-
scope operating at 100 kV (JEOL Ltd., Tokyo, Japan).
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